Visalytics
Visalytics
approved EB-2 (NIW)

Biostatistician I

Biostatistics · Taiwan · 2025-03-09

Processing Time
50 days
Decision Date
2025-03-09
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical drug development for oncology and cardiovascular diseases, which are of significant national importance to U.S. public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's MS degree, publication record, and funding from prestigious institutions like the NIH demonstrate he is well-positioned to succeed.

3 Waiver of Job Offer and Labor Certification Met

The urgency of improving clinical trial precision and the petitioner's unique methodologies make it beneficial for the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's MS degree in biostatistics and a record of 3 peer-reviewed journal articles, 5 conference abstracts, and 38 citations. His influence was evidenced by papers ranked in the top 10–20% of most-cited works in clinical medicine and funding from major institutions like the NIH and AHA. Two expert recommendation letters further confirmed the practical application and originality of his methodologies.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Reference Letters Independent
Reference Letters Dependent
Grants
Original Contributions

Similar Cases

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
Massachusetts 151 days 2025-02-27
The petitioner proposes to refine statistical methodologies for experimental and observational studies to improve the quality of clinical data interpretation. Her work focuses on enhancing the reliability of healthcare research across various disease contexts, specifically ensuring that real-world evidence from large-scale datasets is evaluated with scientific rigor.
View Case

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 367 days 2022-04-05
The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.
View Case

Statistician

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Georgia 8 days 2023-07-18
The petitioner proposes to advance statistical models for drug development and clinical trial methodologies to improve cancer prognosis and treatment outcomes. His work focuses on time-to-event data analysis to enhance the accurate prediction of patient outcomes, risk stratification, and the optimization of clinical trial designs within the pharmaceutical industry.
View Case

Others

Research and Development · China

WeGreened EB-2 (NIW) approved
California 94 days 2025-02-11
The petitioner proposes to conduct data analysis and medical research on disease development to improve diagnosis and treatment outcomes. Her work focuses on advancing data processing techniques, advanced modeling, simulation, and machine learning to provide actionable insights for a range of diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 50 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist